Anesthesia Management in a Patient with 17 Alpha Hydroxylase/17,20 Lyase Deficiency


Creative Commons License

ALKAN M., Ozterlemez N. T., ÖZDEMİR Ç., KURTİPEK Ö., ARSLAN M.

GAZI MEDICAL JOURNAL, vol.29, no.2, pp.152-153, 2018 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.12996/gmj.2018.44
  • Journal Name: GAZI MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.152-153
  • Gazi University Affiliated: Yes

Abstract

Congenital adrenal hyperplasia (CAH) is a an autosomal recessive disorder resulting from a defect in any of several enzymes involved in biosenthesis of cortisol and sex steroids in adrenal cortex. 21-hydroxylase deficiency (90-95%) is the most common form and 17 alpha-hydroxylase / 17,20 lyase deficiency is the least common (<1%). These enzyme deficiencies result in inadequate cortisol production and consequently increased production of corticotropin-releasing hormone (CRH) and adrenocorticotropin hormone (ACTH). Glucocorticoids and sex steroids are used for this hormonal production disorder as a long time treatment. Therefore, anesthesia management is characteristic in this patient group. We aimed to present general anesthesia management for a thyroidectomy operation planned for a 38-year-old female patient with 17 alpha-hydroxylase / 17,20 lyase deficiency with a history of steroid use.